BMRN vs NOMA · P/E 40, rev $1.76B vs rev $6.4K
Biomarin Pharmaceutical Inc (BMRN) versus NOMADAR Corp. Class A Common Stock (NOMA) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
NOMADAR Corp. Class A Common Stock (NOMA) is a leisure company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported NOMA revenue for 2025-12-31 was $6.4K. Net income was -$2.8M. Revenue was down 20.5% from 2024-12-31 to 2025-12-31. NOMA currently screens at market cap $58.4M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NOMA currently screens at market cap $58.4M.
Not investment advice. Open the BMRN and NOMA stock pages for the full models.
Not investment advice.